Our Team
Worth Noting
Recent publications from the Ashley Lab
Ashley Lab in the news
What's Happening Now
View our current Cardiomyopathy Seminar Series, held each Tuesday at noon
Principal Investigator: Dr. Euan Ashley
Ziad Ali: Ziad is a fellow in Cardiovascular Medicine at Stanford Hospital and Clinics. After initially training in medicine andsurgery in Cambridge, Ziad joined the Department of Cardiovascular Medicine at the University of Oxford as a Wellcome Trust Clinical Training Fellow. He trained in cardiovascular surgery prior to embarking on a career as a clinician scientist in cardiovascular medicine. He has recently joined the Department of Cardiovascular Medicine at Stanford University. Ziad’s research focuses on the exaggerated biological response to cardiovascular interventions such as venous bypass surgery and percutaneous coronary intervention. His investigative approach utilizes murine models of venous bypass surgery and his own recently developed murine model of balloon angioplasty and stenting. Using these models Ziad has been investigating the role of the endothelium and redox balance in the response to vascular injury and in particular the critical roles of endothelial nitric oxide synthase (eNOS) and angiotensin II (AngII) in these responses. In his spare time, which seems to be spread few and far between, he enjoys spending time with family and friends and shooting hoops.
Selected Publications:
1. Ali ZA, Bursill CA, Douglas GD, McNeill E, Papaspyridinos M, Akhtar AM, Alp NJ, Greaves DR, Channon KM. CCR2-Mediated Anti-inflammatory Effects of Endothelial Tetrahydrobiopterin Inhibit Vascular Injury Induced Accelerated Atherosclerosis. Circulation. 2008;in press.
2. Ali ZA, Callaghan CJ, Nouraei R, Ali AA, Lim E, Dutka DP, Boyle J, Varty K, Gaunt ME. Remote ischemic preconditioning reduces myocardial injury after abdominal aortic aneurysm repair. Circulation. 2007;116:(11)I98-105.
3. Ali ZA, Alp NJ, Lupton H, Arnold N, Greaves DR, Gunn J, Channon KM. Increased In-Stent Stenosis in Apolipoprotein-E Knockout Mice: A Novel Mouse Model of Balloon Angioplasty and Stenting. Arterioscler Thromb Vasc Biol. 2007; 27(4):833-40.
4. Ali ZA, Bursill CB, Choudhury RP, Hu Y, Xu Q, Greaves DR, Channon KM. Adenoviral mediated delivery of a broad spectrum CC-Chemokine Inhibitor reduces vein graft atherosclerosis in apolipoprotein E knockout mice. Circulation. 2005;112:I-235-241.

David Charo: David is a Postdoctoral Fellow in Cardiovascular Medicine. He recently completed his Internal Medicine residency here at Stanford as part of the Clinical Investigator Pathway. He majored in molecular biology at Princeton University and received his medical degree at the University of Rochester in chilly New York. He is originally from the bay area and is excited to be back after spending almost a decade in the east coast.
He previously spent a year as a Sarnoff Fellow working in the lab with Dr. Quertermous and Dr. Ashley. His research interests are with the apelin-APJ pathway and how this signaling system works to increase cardiac contractility.
Selected Publications:
1. Charo DN, Ho M, Ernst K, Chen M, Fajardo G, Ho Y, Kawana M, Sheikh AY, Finsterbach T, Bernstein D, Ashley EA, Quertermous T. Apelin is an endogenous regulator of cardiac function. 2008, Submitted.
2. Yue P, Arai T, Terashima M, Sheikh AY, Cao F, Charo DN, Hoyt G, Robbins RC, Ashley EA, Wu JC, Yang PC, Tsao PS. Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. American Journal of Physiology – Heart and Circulatory Physiology. 2007 May; 292(5):
H2106-18.
3. Tang G, Charo DN, Wang R, Charo IF, Messina L. CCR2 -/- knockout mice revascularize normally in response to severe hindlimb ischemia. Journal of Vascular Surgery. 2004 Oct; 40(4): 786-95.

Selected publications:
1. Dewey FE, Rosenthal D, Murphy DJ Jr, Froelicher VF, Ashley EA. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation. 2008;117(17):2279-87.
2. Dewey FE, Kapoor JR, Williams RS, Lipinski MJ, Ashley EA, Hadley D, Myers J, Froelicher VF. Ventricular arrhythmias during clinical treadmill testing and prognosis. Arch Intern Med. 2008;168(2):225-34.
3. Leeper NJ, Dewey FE, Ashley EA, Sandri M, Tan SY, Hadley D, Myers J, Froelicher V. Prognostic value of heart rate increase at onset of exercise testing. Circulation. 2007;115(4):468-74.
4. Dewey FE, Freeman JV, Engel G, Oviedo R, Abrol N, Ahmed N, Myers J, Froelicher VF. Novel predictor of prognosis from exercise stress testing: heart rate variability response to the exercise treadmill test. Am Heart J. 2007;153(2):281-8.

Selected Publications:
1. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichhorn J, Chen MM, Mahajan R, Agrawal R, Greve J, Robbins R, Patterson A, Bernstein D, Quertermous T (2005) The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65(1):73-82.

Mikael Mattsson: Mikael is a PhD-student in Medical Science at Karolinska Institutet, Stockholm, Sweden. He received a Master's degree in physiology from Karolinska Institutet . His research evolves in the area of exercise induced cardiac fatigue and circulatory adaptations. At the Ashley lab he is involved in the projects "extreme physiology" and "the apelin-APJ pathway".
Selected Publications:
1.Mattsson CM, Enqvist JK, Ekblom B. "The Adventure Racing athlete: a physiological profile." Submitted manuscript.
2.Mattsson CM, Enqvist JK, Brink-Elfegoun T, Johansson PH, Bakkman L, Ekblom B. "Reversed drift in heart rate but increased oxygen uptake at fixed work rate during 24 hours ultra-endurance exercise." Scand J Med Sci Sports accepted Oct 5, 2008.
3.Berg U, Enqvist JK, Mattsson CM, Carlsson-Skwirut C, Sundberg CJ, Ekblom B & Bang P. "Lack of sex differences in the IGF-IGFBP response to ultra endurance exercise." Scand J Med Sci Sports 18(6):706-14, 2008.
4.Fernstrom M, Bakkman L, Tonkonogi M, Shabalina IG, Rozhdestvenskaya Z, Mattsson CM, Enqvist JK, Ekblom B & Sahlin K. "Reduced efficiency, but increased fat oxidation, in mitochondria from human skeletal muscle after 24-h ultra-endurance exercise". J Appl Physiol 102(5):1844-9, 2007.

Selected Publications:
1. Wheeler M, Ho M, Knowles JW, Pavlovic A, Ashley EA (2008). Pharmacogenetics of Heart Failure: Evidence, Opportunities, and Challenges for Cardiovascular Pharmacogenomics. Journal of Cardiovascular Translational Research 1(2): 25-36.
2. Perez MV, Wheeler M, Ho M, Pavlovic A, Wang P, Ashley EA (2008). Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels. Journal of Cardiovascular Translational Research 1(1): 155-165.

Selected Publications:
1. Perez MV, Wheeler M, Ho M, Pavlovic A, Wang P, Ashley EA. Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels. J Cardiovasc Translational Res. 2008;1(2): 155-165.

Selected Publications:
1. Wang M, Qu X, Stepkowski SM, Chou TC, Kahan BD. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus. Transplantation. 1996 Feb 15;61(3):458-64.
2. Stepkowski SM, Qu X, Wang ME, Tian L, Chen W, Wancewicz EV, Johnston JF, Bennett CF, Monia BP. Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats. Transplantation. 2000 Aug 27;70(4):656-61.
3. Qu X , Kirken RA, Tian L, Wang M, Bennett CF, Stepkowski SM. Selective inhibition of IL-2 gene expression by IL-2 antisense oligonucleotides blocks heart allograft rejection. Transplantation. 2001 Sep 15;72(5):915-23.
4. Zhang Y, Kirken RA, Furian L, Janczewska S, Qu X, Hancock WW, Wang M, Tejpal N, Kerman R, Kahan BD, Stepkowski SM. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. J Immunol. 2006 Jan 1;176(1):128-37.
Selected Publications:
1. Turcott RG and Pavek TJ “Hemodynamic Sensing using Subcutaneous Photoplethysmography,” Am. J. Phys.- Heart Circ. Phys. 2008;295:H2560-72.

Selected Publications:

Selected Publications:
1. Wheeler MT, Ho M, Knowles, JW, Pavlovic, A, Ashley EA., Pharmacogenetics of Heart Failure: Evidence, Opportunities, and Challenges for Cardiovascular Pharmacogenomics. J Cardiovasc Translational Res. 2008;1(1): 25-36.
2. Ashley EA, Kardos A, Jack ES, Habenbacher W, Wheeler M, Kim YM, Froning J, Myers J, Whyte G, Froelicher V, Douglas P. Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise. J Am Coll Cardiol. 2006;48(3):523-31.
3. Wheeler MT, McNally EM. The interaction of coronary tone and cardiac fibrosis. Cur Atherosclerosis Rep. 2005;7(3):219-26.
4.
Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally EM. Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest. 2004;113(5):668-75.
Alumni
Selected Publications:
1. Ali AA, Thanikachalam M, Lim E, Feccia M, Sudarshan C, Parameshwar J, White P, Large SR. Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation. Eur J Cardiothorac Surg. 2007;31(5):929-33.
2. Ali ZA, Callaghan CJ, Ali AA, Lim E, Munday I, Varty K, Gaunt M. Remote ischemic preconditioning reduces myocardial injury after abdominal aortic aneurysm repair. Circulation. 2007;116(11 Suppl):I98-105.
3. Ali A, Halstead JC, Cafferty F, Sharples L, Rose F, Coulden R, Lee E, Dunning J, Argano V, Tsui S. Are stentless valves superior to modern stented valves? A prospective randomized trial. Circulation. 2006;114(1 Suppl):I535-40.
4. Ali AA, Lim E, Halstead J, Ashrafian H, Ali Z, Khalpey Z, Theodorou P, Chamageorakis T, Kumar P, Jackson C, Pepper J. Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study. J Heart Valve Dis. 2003l;12(4):430-5

Selected Publications:

